The 29 portfolio companies we’ve helped build have attracted more than $2.3B of risk capital, employ close to 1,000 Canadians and have a combined value of $4B.
Precision Nanosystems Inc. creates innovative solutions that empower researchers to harness powerful nanotechnology to transform our understanding and treatment of diseases.